Trial intelligence / Profile preview

PIT-STATION: Effect of Pitavastatin on Lipoprotein Subfraction Profile and Lipid Metabolism

jRCT1091220056Completed

Sponsor
Tokyo Medical and Dental University
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of pitavastatin in dyslipidemia, hyperlipidemia, type 2 diabetes mellitus (T2DM) and 1 more (2 arms), sponsored by Tokyo Medical and Dental University. Started Jan 2011; status: completed.

02

Drugs

pitavastatin
03

Conditions

dyslipidemiahyperlipidemiatype 2 diabetes mellitus (T2DM)obesity

Beyond the preview

Go deeper on jRCT1091220056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call